Detalles de la búsqueda
1.
Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.
Respir Res
; 16: 87, 2015 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26177937
2.
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting ß2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
Respir Res
; 16: 97, 2015 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26283085
3.
Use of simulation to compare the performance of minimization with stratified blocked randomization.
Pharm Stat
; 8(4): 264-78, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18756580
4.
Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial.
Diabetes Care
; 40(2): 201-209, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27913576
5.
Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trial.
Diab Vasc Dis Res
; 13(4): 286-98, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27190087
6.
Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial.
Curr Med Res Opin
; 28(9): 1465-74, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22816729
Resultados
1 -
6
de 6
1
Próxima >
>>